WallStreetZenWallStreetZen

NASDAQ: CYCC
Cyclacel Pharmaceuticals Inc Stock Ownership - Who owns Cyclacel Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cyclacel Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David E. Lazar10% Owner2025-07-306,750$12.36
$83.43kSell
David E. LazarInterim CEO2025-02-26194,628,820$0.03
$5.45MSell

1 of 1

CYCC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYCC insiders and whales buy or sell their stock.

CYCC Shareholders

What type of owners hold Cyclacel Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wong Sing Ee Doris8,692.73%194,628,820$1.42BInsider
Austin W. Greenhouse David M. Marxe125.36%2,806,900$20.55MInsider
Stanley Morgan101.69%2,276,852$16.67MInsider
James E. Flynn61.86%1,385,091$10.14MInsider
Kevin C. Tang19.01%425,700$3.12MInsider
Kok Hui Tan11.17%250,000$1.83MInsider
Kee Wee Ho11.17%250,000$1.83MInsider
Jien Shiung Ho11.17%250,000$1.83MInsider
Sukses Engineering Sdn Bhd Suria11.17%250,000$1.83MInsider
Citadel Advisors LLC8.02%179,555$1.31MInstitution

1 of 3

CYCC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYCC0.16%99.84%Net SellingNet Selling
MBRX1.43%20.90%Net BuyingNet Buying
CMMB1.02%4.09%
XFOR26.19%73.81%Net Selling
BCAB26.97%35.39%Net SellingNet Selling
View Top Biotech Stocks

Cyclacel Pharmaceuticals Stock Ownership FAQ

Who owns Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals (NASDAQ: CYCC) is owned by 14.83% institutional shareholders, 9,080.59% Cyclacel Pharmaceuticals insiders, and 0.00% retail investors. Wong Sing Ee Doris is the largest individual Cyclacel Pharmaceuticals shareholder, owning 194.63M shares representing 8,692.73% of the company. Wong Sing Ee Doris's Cyclacel Pharmaceuticals shares are currently valued at $1.56B.

If you're new to stock investing, here's how to buy Cyclacel Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.